Correction to “Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension”
Clinical and Translational Science · 2026-11 · 19 (11)
DOI: 10.1111/cts.70754 ↗Kurz gefasst
Korrektur in der Zeitschrift Clinical and Translational Science, online erschienen am 05.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National High Level Hospital Clinical Research Funding
- The Artificial Intelligence and Information Technology Application Fund of Fuwai Hospital, Chinese Academy of Medical Sciences
- Beijing Natural Science Foundation
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation
Zitieren
APA
(2026). Correction to “Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension”. Clinical and Translational Science, 19(11). https://doi.org/10.1111/cts.70754
Vancouver
Correction to “Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension”. Clinical and Translational Science. 2026;19(11). doi:10.1111/cts.70754
BibTeX
@article{euvimed2026,
title = {Correction to “Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension”},
journal = {Clinical and Translational Science},
year = {2026},
volume = {19},
number = {11},
doi = {10.1111/cts.70754}
}
EUVIMED